Eton Pharmaceuticals, Inc. Depreciation
Eton Pharmaceuticals, Inc. (ETON) reported Depreciation of $44.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. depreciation for the quarter ending 2026-06-30 was $22.00K, a 450.00% increase year-over-year.
- Eton Pharmaceuticals, Inc. depreciation for the quarter ending 2026-03-31 was $22.00K, a 83.33% increase year-over-year.
- Eton Pharmaceuticals, Inc. depreciation for the quarter ending 2025-12-31 was $17.00K, a 55.26% decline year-over-year.
- Eton Pharmaceuticals, Inc. depreciation for the quarter ending 2025-09-30 was $8.00K, a 33.33% decline year-over-year.
- Eton Pharmaceuticals, Inc. depreciation for fiscal 2025 was $41.00K, a 18.00% decline from fiscal 2024.
- Eton Pharmaceuticals, Inc. depreciation for fiscal 2024 was $50.00K, a 13.64% increase from fiscal 2023.
- Eton Pharmaceuticals, Inc. depreciation for fiscal 2023 was $44.00K, a 33.33% decline from fiscal 2022.
- Eton Pharmaceuticals, Inc. depreciation for fiscal 2022 was $66.00K, a 57.42% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 8 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $44.00K 10-Q · filed 2026-08-13 | $61.00K derived: sum of 3 quarters · filed 2026-08-13 | $69.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $22.00K 10-Q · filed 2026-05-14 | $39.00K derived: sum of 2 quarters · filed 2026-05-14 | $47.00K derived: sum of 3 quarters · filed 2026-05-14 | $51.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $25.00K derived: sum of 2 quarters · filed 2026-03-19 | $29.00K derived: sum of 3 quarters · filed 2026-08-13 | $41.00K 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $12.00K derived: sum of 2 quarters · filed 2026-08-13 | $24.00K 10-Q · filed 2025-11-06 | $62.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $16.00K 10-Q · filed 2026-08-13 | $54.00K derived: sum of 3 quarters · filed 2026-08-13 | $66.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-14 | $50.00K derived: sum of 2 quarters · filed 2026-05-14 | $62.00K derived: sum of 3 quarters · filed 2026-05-14 | $74.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $50.00K derived: sum of 2 quarters · filed 2026-03-19 | $62.00K derived: sum of 3 quarters · filed 2026-03-19 | $50.00K 10-K · filed 2026-03-19 | |||
| 2024-09-30 | $12.00K 10-Q · filed 2024-11-12 | $24.00K derived: sum of 2 quarters · filed 2024-11-12 | $12.00K 10-Q · filed 2025-11-06 | $38.00K 10-Q · filed 2024-11-12 | $50.00K derived: sum of 4 quarters · filed 2026-03-19 | ||
| 2024-06-30 | $12.00K 10-Q · filed 2024-08-08 | $23.00K 10-Q · filed 2025-08-07 | $26.00K 10-Q · filed 2024-08-08 | $38.00K derived: sum of 3 quarters · filed 2026-03-19 | $47.00K derived: sum of 4 quarters · filed 2026-03-19 | ||
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-13 | $26.00K derived: sum of 2 quarters · filed 2026-03-19 | $35.00K derived: sum of 3 quarters · filed 2026-03-19 | $45.00K derived: sum of 4 quarters · filed 2026-03-19 | |||
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $21.00K derived: sum of 2 quarters · filed 2026-03-19 | $31.00K derived: sum of 3 quarters · filed 2026-03-19 | $44.00K 10-K · filed 2026-03-19 | |||
| 2023-09-30 | $9.00K 10-Q · filed 2024-11-12 | $19.00K derived: sum of 2 quarters · filed 2024-11-12 | $32.00K 10-Q · filed 2024-11-12 | $45.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | $10.00K 10-Q · filed 2024-08-08 | $23.00K 10-Q · filed 2024-08-08 | $36.00K derived: sum of 3 quarters · filed 2025-03-18 | $50.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-09 | $26.00K derived: sum of 2 quarters · filed 2025-03-18 | $40.00K derived: sum of 3 quarters · filed 2025-03-18 | $58.00K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $27.00K derived: sum of 2 quarters · filed 2025-03-18 | $45.00K derived: sum of 3 quarters · filed 2025-03-18 | $66.00K 10-K · filed 2025-03-18 | |||
| 2022-09-30 | $14.00K 10-Q · filed 2023-11-09 | $32.00K derived: sum of 2 quarters · filed 2023-11-09 | $53.00K 10-Q · filed 2023-11-09 | $76.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | $18.00K 10-Q · filed 2023-08-10 | $39.00K 10-Q · filed 2023-08-10 | $62.00K derived: sum of 3 quarters · filed 2024-03-14 | $86.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | $21.00K 10-Q · filed 2023-05-11 | $44.00K derived: sum of 2 quarters · filed 2024-03-14 | $68.00K derived: sum of 3 quarters · filed 2024-03-14 | $92.00K derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $47.00K derived: sum of 2 quarters · filed 2024-03-14 | $71.00K derived: sum of 3 quarters · filed 2024-03-14 | $155.00K 10-K · filed 2024-03-14 | |||
| 2021-09-30 | $24.00K 10-Q · filed 2021-11-16 | $48.00K derived: sum of 2 quarters · filed 2021-11-16 | $132.00K 10-Q · filed 2021-11-16 | ||||
| 2021-06-30 | $24.00K 10-Q · filed 2021-08-16 | $108.00K 10-Q · filed 2021-08-16 | |||||
| 2021-03-31 | $84.00K 10-Q · filed 2021-05-13 | ||||||
| 2020-09-30 | $86.00K 10-Q · filed 2021-11-16 | $173.00K derived: sum of 2 quarters · filed 2021-11-16 | $260.00K 10-Q · filed 2021-11-16 | ||||
| 2020-06-30 | $87.00K 10-Q · filed 2021-08-16 | $174.00K 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $87.00K 10-Q · filed 2021-05-13 | ||||||
| 2019-09-30 | $86.00K 10-Q · filed 2020-11-12 | $175.00K derived: sum of 2 quarters · filed 2020-11-12 | $197.00K 10-Q · filed 2020-11-12 | $215.00K derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $89.00K 10-Q · filed 2020-08-12 | $111.00K 10-Q · filed 2020-08-12 | $129.00K derived: sum of 3 quarters · filed 2020-08-12 | $144.00K derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-14 | $40.00K derived: sum of 2 quarters · filed 2020-05-14 | $55.00K derived: sum of 3 quarters · filed 2020-05-14 | $66.00K derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $33.00K derived: sum of 2 quarters · filed 2019-11-14 | $44.00K derived: sum of 3 quarters · filed 2019-11-14 | $51.00K 10-K · filed 2019-03-25 | |||
| 2018-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $26.00K derived: sum of 2 quarters · filed 2019-11-14 | $33.00K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $18.00K 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | $7.00K 10-Q · filed 2019-05-07 | ||||||
| 2017-12-31 | $11.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |